https://www.selleckchem.com/pr....oducts/prostaglandin
In young elderly patients THA is a common treatment for displaced FNF in Sweden. Patients in this segment treated with HA differ from patients treated with THA and IF, with baseline results in PROM indicating poorer health and function, as well as higher mortality and lower response rates. We found no differences in crude mortality between IF and THA treatment, and no significant influence from treatment on PROM outcome comparing THA and IF.Survival rates for oral squamous cell carcinoma (OSCC) has remained stagnant in
Beğen
Yorum Yap
Paylaş
